Background: Secondary orbital implantation surgery can be complex due to scarring of the orbital tissues and can be complicated by implant exposure and extrusion. Purpose: To evaluate the incidence and risk factors of implant exposure and extrusion following secondary alloplastic orbital implantation surgery in anophthalmic patients. Methods: Retrospective analysis of a consecutive series of patients who underwent secondary placement of an alloplastic orbital implant by one surgeon between 2001 and 2016 in the Rotterdam Eye Hospital. Outcome parameters: implant exposure or extrusion. Other complications. Results: Sixty-three patients underwent secondary orbital placement of scleralwrapped acrylic (60) or silicone (three) spherical implants. A subset of 25 patients had undergone earlier secondary orbital implant placement (by other surgeons) with exposure/extrusion necessitating additional implant surgery. Two patients were excluded due to lack of follow-up (<3 months). Mean age was 49 years (range: 1-84.5 years). The mean follow-up was 4.1 years (range: 0.25-13, 6 years). Implant exposure or extrusion occurred in six of 18 (33%) patients in whom no muscle had been reattached during secondary orbital implantation and in five of 43 (12%) patients in whom the extraocular recti muscles had been attached, but the follow-up time was shorter for the latter group. Surgical treatment for implant exposure/ extrusion was required in eleven of 61 patients (18%). Other complications included postoperative volume deficiency despite optimal prosthesis (five of 61, 8%), inclusion cysts (four of 61, 7%) and conjunctivitis sicca (two of 61, 3%). Seven of 61 (11%) patients required fornix deepening and seven (11%) blepharoptosis correction. Conclusion: Secondary orbital implantation of sclera-wrapped alloplastic implants was complicated by implant extrusion or exposure in 12% of cases in which the extraocular muscles were attached to the implant.
Introduction
Anophthalmia leads to cosmetic deformity. Placement of an orbital implant after eye removal is essential to prevent volume deficiency, to form a socket which is able to carry an ocular prosthesis that simulates the normal fellow eye and to provide some degree of motility. Causes for anophthalmic surgery include trauma, intractable glaucoma, corneal ulcer, ocular inflammation and infection, or tumours.
In secondary orbital implantation surgery, an implant (alloplastic or dermofat graft) is placed into the intraconal space of the anophthalmic orbit following earlier eye removal or exposed implant removal. The aim of the operation is to restore orbital volume for an optimal functional and cosmetic result. Reported complications of the operation include chronic pain or discomfort, exposure or extrusion of the implant, infections, conjunctival contracture, entropion, ectropion and blepharoptosis, as well as an inability to wear an artificial eye (Quaranta-Leoni et al. 2015) . In the Rotterdam Eye Hospital, we routinely use alloplastic, donor sclera-covered spherical implants for orbital volume replacement. While we have a preference to use 20-or 22-mm-sized implants after eye removal, in secondary orbital placement surgery, the size of the selected implants tends to be smaller (16-20 mm) because of a reduced amount of conjunctiva and/or severe postinflammatory scarring of orbital tissues. In cases of significant mucosal shortage, dermofat grafting is often preferred over the use of (small) alloplastic implants.
The aim of this study is to evaluate the outcome of our secondary orbital implantation procedures using alloplastic donor sclera-wrapped implants and to compare our results with previously reported studies on this topic.
Materials and Methods
This was a single-institution, retrospective analysis of a consecutive series of patients who had undergone secondary placement of an alloplastic, sclerawrapped, spherical orbital implant in the Rotterdam Eye Hospital, the Netherlands. The study was approved by the institutional review board, with all research adhering to the principles outlined in the Declaration of Helsinki (October, 2013) , the guideline for Good Clinical Practice (CPMP/ICH/135/95) and the Medical Research Involving Human Subjects Act (WMO; 2006) . The clinical charts of 63 patients who underwent a secondary orbital implantation procedure, under the care of one orbital surgeon (DP) from January 2001 to January 2016, were analysed. Primary surgery had been performed by other surgeons, either in the same hospital or elsewhere. Some patients had an additional history of (failed) spherical orbital implant surgery or dermofat grafting.
Information was obtained about patient demographics, ocular diagnosis and laterality, prior ophthalmic surgery (indication, year, technique used), previous orbital radiotherapy, date of secondary implantation, the time interval between eye removal or implant extrusion and secondary orbital implantation, and the secondary orbital implantation (technique, implant material and size). Main outcome parameters were implant exposure or extrusion following the secondary implant surgery in the Rotterdam Eye Hospital. Secondary outcome parameters included infection, volume deficiency (presence of deep upper eyelid sulcus or enophthalmos despite optimal prosthesis), the presence of inclusion cysts, conjunctivitis sicca or an inability to wear a prosthesis.
Information was also gathered about additional surgeries (ptosis correction, fornix deepening) after the secondary implantation.
Surgical technique
In this technique, under general anaesthesia, following placement of a speculum, the conjunctiva and Tenon's capsule were cut horizontally in the centre of the socket. Adhesiolysis was performed using straight scissors, both towards the intraconal space and the sub-Tenon spaces in between the extraocular muscles. The intraconal space was enlarged through dissection assisted by digital manipulation (for tactile feedback). In the (most recent) cohort of patients treated with extraocular muscle fixation, the recti muscles were retrieved and maintained by 6.0 Vicryl traction sutures. This step was not performed in the early cohort of treated patients. In these, an intraconal pocket was created after which the orbital cavity was closed anteriorly. An alloplastic (acrylic or silicone) implant wrapped in donor sclera was inserted deep in the intraconal space. Implants smaller than 20 mm were chosen in case of shortage of conjunctival lining. The extraocular recti muscles were sutured to the donor sclera at the anterior surface, near the donor optic nerve stump. In patients who had undergone evisceration, the spherical implant was either wrapped in autologous sclera (if available and of good quality) or in donor sclera, or both (autologous sclera and anterior donor sclera patch). All implants were wrapped in sclera for possible better integration. The sclera was sutured together with multiple interrupted or matrass Vicryl sutures. In all patients, Tenon's capsule and conjunctiva were sutured in two orin later treated patients -in one layer with rapidly absorbing Vicryl 6.0 sutures (Verhoekx et al. 2016 ). An adequately sized sterile glass prosthesis was selected and positioned within the conjunctival fornices (Muller company, Rotterdam, Wiesbaden). A pressure bandage was left for 1 day. Following surgery, all patients were treated with topical antibiotic therapy.
Patients were monitored for the occurrence of any of the aforementioned complications at postoperative examinations at 1 week and at 3 months. Hereafter, patients were instructed to return to our clinic in case of any socket or eyelid problems. A subset of patients desired check-ups at yearly intervals and also for their remaining eye.
Results
Sixty-three patients underwent secondary orbital placement of scleral-wrapped acrylic (60) or silicone (three) spherical implants. Two patients were excluded due to a lack of follow-up (<3 months), so 61 patients were included. Patients' characteristics and surgical details are presented in Table 1 .
The major cause of eye removal (enucleation or evisceration) was trauma (28 of 61 eyes, 46%), followed by retinoblastoma (nine of 61 eyes, 15%). Other causes included congenital atrophy of the eye (seven of 61, 11.4%), postsurgical phthisis (six of 61, 9.8%), infections (four of 61, 6.5%), melanoma (three of 61, 4.9%), chronic intra-ocular inflammation (three of 61, 4.9%) and diabetes (one of 61, <2%). None of our patients had undergone previous radiotherapy to the orbit.
In 17 patients (28%), the reason for secondary implantation was postenucleation socket syndrome (PESS) without an implant, in nine (15%) eyes PESS with an implant, in 30 (49%) eyes the reason was recurrent exposure of the implant, and in 5 (8%) it was because of complications related to a previously placed Allen implant. Table 2 summarizes main and secondary outcome measures.
All the eleven patients who presented with exposure or extrusion after their secondary implant in the Rotterdam Eye Hospital were reoperated by DP. Five (45%) were explanted and the socket closed without any further implantation, and six (55%) underwent an implant exchange. Of these, four received a smaller sized implant (16 mm Acryl instead of 18 mm Acryl), and two received a same size implant (16 mm Acryl). Only one patient then continued to present with recurrent exposures but eventually the socket could be stabilized via mobilization of the extraocular muscles over the wound and closure of Tenon's capsule and conjunctiva.
When analysing the rate of complications in relation to the type of primary surgery, seventeen of the 29 complications occurred in patients who had initially been enucleated, eleven in patients who had initially been eviscerated and one in a patient whose primary surgery was unknown (after a trauma in 1984).
The median implant diameter in our group was 20 mm, with a range of 16-22 mm.
An analysis of the number of complications in relation to implant size showed that nineteen of the total 35 secondary implants of 18 mm diameter (54%) presented postoperative complications, as compared to six out of a total of 12 implants of 16 mm (50%). The other three complications occurred in implants of, respectively, 19 mm (2) and 20 mm (1) diameter.
There was no higher frequency of implant exposure or extrusion in patients who were never treated with an orbital implant following eye removal versus patients who had received an orbital implant following eye removal (with subsequent extrusion) before the secondary orbital implant surgery in the Rotterdam Eye Hospital.
Six of 61 (10%) patients required fornix deepening after the secondary implantation, two at the same date as the secondary implantation, 1 after 3 months, one 1 year later, one 2 years later, and the last patient 2, 5 and again 7 years after surgery. Six (10%) of our patients required blepharoptosis correction that was performed between 2 months and 2 years after the secondary implant surgery.
Discussion
In this study, secondary orbital implantation of spherical, sclera-wrapped alloplastic implants was associated with an eight per cent risk of implant extrusion and a ten per cent chance of implant exposure, adding up to an 18% risk of anterior surface breakdown.
With the same surgeon doing all the operations, the implant material and wrapping did not differ much in our patient group. The most important finding in our series was the reduced rate of extrusion or exposure in the group of patients in whom the extraocular muscles were separately identified and reattached to the implant, in comparison with the group of patients whose extraocular muscles had not been individually identified and reattached. It is not illogical to hypothesize that deeper placed and fixed orbital implants with an anterior layer of well-vascularized muscles underneath Tenon's layer and conjunctiva have a smaller chance of extrusion; however, we cannot exclude that the difference might result from a shorter follow-up of the first group.
Several published studies have analysed outcomes and complications of secondary alloplastic, spherical orbital implants. Different materials have been used, such as pegged and unpegged bioceramic orbital implants (Karslioglu et al. 2012 ), a mix of silicone, hydroxyapatite, aluminium oxide and porous polyethylene (Sundelin & Dafgard Kopp 2015) , or polyglactin mesh-wrapped bioceramic implants (Quaranta- Leoni et al. 2015) .
Most authors agree that secondary placement of an implant into the anophthalmic socket is a more complicated surgical procedure than primary implantation and is associated with a higher frequency of complications (Sundelin & Dafgard Kopp 2015; Shoamanesh et al. 2015; Jongman et al. 2016; Mourits et al. 2016; Verhoekx et al. 2016 ). This has been explained by the disruption of orbital anatomy, collapse of orbital contents, loss of orbital fat, socket contracture, scarred orbital tissues and extraocular muscles, socket deformity, as well as by contracture and loss of the conjunctival fornices (Sundelin & Dafgard Kopp 2015) .
In 2009, Shoamanesh et al. (2007) published one of the largest retrospective studies of secondary orbital implantations by one surgeon. They reported on 215 patients who underwent secondary orbital implantation with a mean follow-up of 23.7 months (range 1-57). The overall complication rate after secondary implantation was 82%, and the prevalence of exposure or extrusion was 12%. The authors used a similar surgical technique to ours, wrapping all implants and always suturing the four recti muscles onto the anterior surface of the wrap. However, the implant sizes used in this study varied considerably and it must be noted that the number of complications includes acrylic as well as Medpore implants.
In 2015, in their retrospective review of a group of 71 patients undergoing secondary orbital implantations with a mean follow-up of 3 years (range: 0-9 years) and again a variety of implants, Sundelin & Dafgard Kopp (2015) reported a 34% overall complication rate, consisting for 6% of exposure or extrusion, the rest being migration of the implant, inadequate volume, infection or persistent socket oedema. In 18%, the extraocular muscles had been reattached to the implant and 50% of implants were wrapped. The size of the implant seemed not to be a statistically significant risk factor for overall complications; however, suturing of the muscles to the implant seemed to be a negative factor for the success of surgery in this series.
In contrast to these large studies reporting a relatively high incidence of complications, in 2015, Quaranta-Leoni et al. published a retrospective series of 86 patients treated with secondary orbital placement of a hydroxyapatite polyglactin mesh-wrapped implant (QuarantaLeoni et al. 2015) . Their mean followup was 6.4 years (range: 2-15 years). Unfortunately, it does not appear clearly from their study whether the extraocular muscles were sutured to the wrap or not but the authors reported only a 5% rate of exposure, occurring in previously enucleated patients and occurring early (at 12 weeks) without any recurrence after treatment with a hard palate graft. The authors explain their low complication rate by hypothesizing that the disadvantage of using autologous wrapping material is that it induces inflammation and scarring, whereas a reabsorbable layer wrapped around the implant such as the polyglactin mesh wrap is capable to resist the melting of the early phase of other materials. Moreover, with polyglactin mesh, a fibrovascular capsule forms external to the mesh and replaces it within 3 months. They argue that an incorrect surgical procedure with superficial positioning of the implant that drags orbital fat deep down the socket is a cause for higher numbers of exposure reported by previous authors and that localization of extraocular muscles may not be necessary, provided that the implant is placed above the inferior rectus muscle. However, in a review of different implant materials in the year 2000, Custer stated that unlike alloplastic implants (silicone, acryl, glass), exposed hydroxyapatite implants generally do not extrude (Custer 2000) . In fact, small defects may heal spontaneously and this may contribute to explain the small number of complications in QuarantaLeoni's group.
As stated by Karslioglu et al. (2012) , managing of exposure is challenging. Early exposures (<3 months) are likely to be due to incorrect wound closure techniques, inappropriate implant size, inadequate seating of the implant, closure of the wound under tension, trauma or infection. Late exposures (>3 months) are thought to result from friction, inflammation, pressure points from the prosthesis, infection and other socket problems. We report an overall rate of early complications (including infection and volume deficiency) in thirteen per cent of our patients and of late complications in 28 per cent.
In our group of patients, thirteen per cent (four of 61) presented a postoperative residual volume deficiency despite optimal prosthesis. Of these, two patients received a Medpore orbital floor implant and one a Medpore orbital floor implant as well as a dermal fat graft. All anophthalmic socket patients are at risk of having some degree of volume deficit, as the need for volume must be balanced against the risk of extrusion if the implant is too large and also to make good conditions for the ocularist to fit a prosthesis (Sundelin & Dafgard Kopp 2015) . A significant volume deficit results when a 24-mm globe is replaced by a 16-22 mm sphere (Custer 2000) . Also, there is some degree of orbital fat absorption following surgery, with continuous volume deficiency during the months to follow (Quaranta-Leoni et al. 2015) . Our series presented with a lower percentage of postoperative residual volume deficiency than most other similar published studies (29% in Sundelin & Dafgard Kopp 2015, 16; % in QuarantaLeoni et al. 2015) , but this may result from different assessment methods.
Fornix-deepening surgery was performed in ten per cent of our patients (six of 61), which is lower than that reported by Shoamanesh et al. (2007) (22.3%) in one of the largest studies of secondary orbital implantations published, including 215 patients. In five of our six patients, the postoperative result was good; only one patient needing two more fornix-deepening surgeries years later. As to blepharoptosis, eleven per cent of our patients required surgical correction of a lid asymmetry, with a satisfactory postoperative outcome. Shoamanesh et al. (2007) reported that eight per cent of their patients with secondary implantation required surgery for ptosis correction. Blepharoptosis should only be corrected following placement of an optimally fitting artificial eye. A mild undercorrection is preferred to camouflage the presence of an artificial eye.
Contrary to other reports, we did not observe any case of implant migration other than extrusion, despite the fact that we did not use porous implants.
In summary, although we report a fair amount of complications after secondary implantation, the majority of these complications are minor and can be quite easily treated. It is important to thoroughly inform patients prior to surgery, explaining that the risk of complications is higher than for their primary surgery and that several surgeries might be needed over long laps of time. In this series, we report our findings on a relatively homogenous series of secondary orbital sclera-wrapped alloplastic implants, and we show that a technique employing anterior fixation of extraocular muscles carries a 12% risk of implant exposure or extrusion. Inability to wear a prosthesis 6 (10) Sicca 2 (3) Inclusion cyst 4 (7)
